Nuclear Receptors: Development, Physiology and Disease
joint with Nuclear Receptors: Signaling, Gene Regulation and Cancer
Organizer(s): Carl S. Thummel, David D. Moore and Joyce J. RepaDate: March 21 - 26, 2010
Location: Keystone Resort, Keystone, CO, USA
Nuclear receptors represent a family of ligand-regulated transcription factors that play central roles in development, physiology, and metabolism. Upon binding small lipophilic hormones and metabolites, such as steroids, fatty acids, and bile acids, nuclear receptors switch their regulatory status, reprogramming gene expression in target tissues. Current research is aimed at defining roles for these receptors in normal development and metabolism as well as better understanding how nuclear receptor dysfunction contributes to diabetes, cancer, cardiovascular disease, obesity, and neuronal disorders. Nuclear receptors are also a major target for drug development, with many compounds on the market and several in ongoing human trials. This meeting will highlight recent breakthroughs in nuclear receptor research, promote interactions between scientists from industry and academia, and provide opportunities for senior scientists to interact with younger researchers and trainees.
Scholarship Deadline: November 23 2009
Discounted Abstract Deadline: November 23 2009
Abstract Deadline: December 28 2009
Discounted Registration Deadline: January 22 2010
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Merck & Co., Inc.